Potential for Genomics to Help Guide Preventive Strategies in Psychiatry

Currently, genomic testing in psychiatry should not be used for population-wide screening but may have value as a targeted clinical resource whose utility depends on timing, context, and purpose. When applied judiciously and embedded within comprehensive, ethically grounded care pathways, genomic testing holds promise as one component of a more precise, preventive, and patient-centered psychiatry.

Corresponding Authors: Katherine L. Musliner, PhD, MPH, Department of Affective Disorders, Aarhus University Hospital, Palle-Juul Jensens Blvd 175, 8200 Aarhus N, Denmark (klm@clin.au.dk); Wouter J. Peyrot, MD, PhD, Department of Psychiatry, Amsterdam UMC, Oldenaller 1, 1081 HJ Amsterdam, the Netherlands (w.peyrot@amsterdamumc.nl).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.